Home Updates on the versatile quinoline heterocycles as anticancer agents
Article
Licensed
Unlicensed Requires Authentication

Updates on the versatile quinoline heterocycles as anticancer agents

  • Basavarajaiah Suliphuldevara Matada ORCID logo EMAIL logo , Nagesh Gunavanthrao Yernale ORCID logo and Jeelan N. Basha ORCID logo
Published/Copyright: October 26, 2021
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Physical Sciences Reviews
From the journal Physical Sciences Reviews Volume 8 Issue 9

Abstract

Quinoline motifs have befallen significant molecules due to their assortment of interest in medicine, chemical synthesis, coordination chemistry, also in the field of applied chemistry. Therefore, various researchers have produced these molecules as objective structures and studied their natal potential. The current chapter endows with concise attention about cancer, anticancer agents, sources (natural) of quinoline, and together with an innovative scope of quinoline-related medicines. Further, the present section gives knowledge concerned with the anticancer activity of synthesized quinolines and their derivatives.

Keywords: anticancer agents; classical methods; heterocyclic compounds; marketed drugs; natural sources; quinolines
Corresponding author: Basavarajaiah Suliphuldevara Matada, Post Graduate Department of Chemistry, Vijaya College, Bengaluru, 560 004, India, E-mail:

Acknowledgment

Prof. Mruthyunjayaswamy B. H. M. Professor Gulbarga University, Kalaburagi, was gratefully acknowledged due to the assistance and encouragement.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Available from: https://www.medicinenet.com/cancer/article.htm.Search in Google Scholar

2. Available from: https://www.medicalnewstoday.com/articles/323648.Search in Google Scholar

3. Zimmerman, HJ. Drug-induced liver disease. In: Zimmerman, HJ, editor. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.Search in Google Scholar

4. DeLeve, LD. Cancer chemotherapy. In: Kaplowitz, N, DeLeve, LD, editors. Drug-induced liver disease, 3rd ed. Amsterdam: Elsevier; 2013.10.1016/B978-0-12-387817-5.00030-3Search in Google Scholar

5. Wellstein, A. General principles in the pharmacotherapy of cancer. In: Brunton, LL, Hilal-Dandan, R, Knollman, BC, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 13th ed. New York: McGraw-Hill; 2018.Search in Google Scholar

6. Runge, FF. Ueber einige produkte der Steinkohlendestillation. Ann Phys Chem 1834;31:65–7. https://doi.org/10.1002/andp.18341070502.Search in Google Scholar

7. Gerhardt, C. Ueber die chemische Classification der organischen Substanzen (Analysis of chlorplatinates of quinine, strychnine, and quinoleine). J prakt Chem 1843;28:65.10.1002/prac.18430280112Search in Google Scholar

8. Schenck, LM, Bailey, JR. The nitrogen compounds in petroleum distillates. XXII. Isolation and synthesis of 2,3-Dimethyl-4,8-diethylquinoline (I) and 2,3-Dimethyl-4-ethyl-8-n-propylquinoline (II). J Am Chem Soc 1941;63:1365–7.10.1021/ja01850a066Search in Google Scholar

9. Greshoff, M. Recherches sur l’Echinopsine, nouvel alcaloïde crystallisc. Recl Trav Chim Pays-Bas 1900;19:360–3. https://doi.org/10.1002/recl.19000191104.Search in Google Scholar

10. Troger, J, Mueller, W. The isomerization and decomposition of cusparine. Arch Pharm 1914;252:459–64. https://doi.org/10.1002/ardp.v252:9.10.1002/ardp.v252:9Search in Google Scholar

11. Spath, E, Papaioanou, G. Über Phenolbasen der Angosturarinde: Synthese des Galipolins. Monatsh Chem 1929;52:129–35. https://doi.org/10.1007/bf02715981.Search in Google Scholar

12. Troger, J, Runne, H. Beiträge zur Erforschung der Angosturaalkaloide. Arch Pharm 1911;249:174–82. https://doi.org/10.1002/ardp.19112490303.Search in Google Scholar

13. Basavarajaiah, SM, Mruthyunjayaswamy, BHM. Synthesis and anti-microbial activity of some new 5-substituted-N1-[(1E)-(2-Hydroxyquinolin-3-yl)methylene]-3-phenyl-1H-indole-2-carbohydrzide derivatives. Heterocycl Commun 2009;15:217–21. https://doi.org/10.1515/hc.2009.15.3.217.Search in Google Scholar

14. Basavarajaiah, SM, Mruthyunjayaswamy, BHM. Synthesis and antimicrobial activity of some 5-substituted-3-phenyl-Nβ-(Substituted-2-oxo-2H-pyrano[2,3-b]quinoline-3-carbonyl)-1H-indole-2-carboxyhydrazide. Chem Pharm Bull 2009;57:557–61.10.1248/cpb.57.557Search in Google Scholar

15. Basavarajaiah, SM, Mruthyunjayaswamy, BHM. Synthesis and antimicrobial activity of novel 5-substituted-N-(substituted-2H-[1,3]oxazino[6,5-b]quinolin-3(4H)-yl)-3-phenyl-1H-indole-2-carboxamides. Indian J Chem, Sect B 2016;55B:1511–6.Search in Google Scholar

16. Basavarajaiah, SM, Mruthyunjayaswamy, BHM. Pharmacological activities of 5-substituted-N-(substituted-2H-[1, 3]oxazino[6, 5-b]quinolin-3(4H)-yl)-3-phenyl-1H-indole-2-carboxamides. Int J Creativ Res Thoughts 2020;8:232–6.Search in Google Scholar

17. Matada, BS, Yernale, NG. The contemporary synthetic recipes to access versatile quinoline heterocycles. Synth Commun 2021;51:1133–362. https://doi.org/10.1080/00397911.2021.1876240.Search in Google Scholar

18. Sheshandrakumar, KN, Srividya, J, Narayanaswamy, BJ, Umesha, K, Basavarajaiah, SM. Synthesis and evaluation of biological activity of some new 3, 7-substituted 2H-pyrano/thiopyrano [2, 3-b] quinolin-2-ones. Indian J Heterocycl Chem 2017;27:281–6.Search in Google Scholar

19. Matada, BS, Pattanashettar, R, Yernale, NG. A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg Med Chem 2021;32:115973–11602. https://doi.org/10.1016/j.bmc.2020.115973.Search in Google Scholar PubMed

20. Wall, ME, Wani, MC, Cook, CE, Palmer, KH, McPhail, AI, Sim, GA. Plant antitumor agents. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 1966;88:3888–90. https://doi.org/10.1021/ja00968a057.Search in Google Scholar

21. Zhihu, D, Shou, CT, Priya, W, Xiaolong, Y, Alan, P, Andrejs, L. The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochem Pharmacol 2002;63:1415–21.10.1016/S0006-2952(02)00902-4Search in Google Scholar

22. Haseeb, A, Shannon, RS, Jorien, B, Nihal, A. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Canc Lett 2007;249:198–205.10.1016/j.canlet.2006.08.018Search in Google Scholar

23. Santos, AC, Adkilen, P. The alkaloids of argemone mexicana. J Am Chem Soc 1932;54:2923–6. https://doi.org/10.1021/ja01346a037.Search in Google Scholar

24. Pitts, BJ, Meyerson, LR. Drug Dev Res 1981;1:4349–53. https://doi.org/10.1002/ddr.430010105.Search in Google Scholar

25. Ortiz, LMG, Tillhon, M, Parks, M, Dutto, I, Prosperi, E, Savio, M, et al.. Multiple effects of berberine derivatives on colon cancer cells. BioMed Res 2014;2014:1–8. https://doi.org/10.1155/2014/924585.Search in Google Scholar PubMed PubMed Central

26. Cai, W, Hassanib, M, Karki, R, Walter, ED, Koelsch, KH, Seradj, H, et al.. Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents. Bioorg Med Chem 2010;18:1899–904. https://doi.org/10.1016/j.bmc.2010.01.037.Search in Google Scholar PubMed PubMed Central

27. Tan, GT, Pezzuto, JM, Kinghorn, AD, Hughes, SH. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J Nat Prod 1991;54:143–8. https://doi.org/10.1021/np50073a012.Search in Google Scholar PubMed

28. Rao, KV, Biemann, K, Woodward, RBJ. The structure of streptonigrin. J Am Chem Soc 1963;85:2532–8. https://doi.org/10.1021/ja00899a051.Search in Google Scholar

29. FDA approves cometriq to treat rare type of thyroid cancer; 2012. https://www.fiercepharma.com/pharma/fda-approves-cometriq-to-treat-rare-type-of-thyroid-cancer.Search in Google Scholar

30. British National Formulary. BNF 69. British Medical Association; 2015:624 p. https://rudiapt.files.wordpress.com/2017/11/british-national-formulary-69.pdf.Search in Google Scholar

31. FDA approves Xtoro to treat swimmer’s ear. Food and Drug Administration; 2014. https://www.thepharmaletter.com/article/fda-approves-alcon-s-xtoro-to-treat-swimmer-s-ear?__cf_chl_jschl_tk__=pmd_7e8oOzGOl0GgWbwBBWN.TjfKVatsItw0o5jHfBeIGsI-1633424016-0-gqNtZGzNAlCjcnBszQel.Search in Google Scholar

32. Horstmann, MA, Hassenpflug, WA, zur Stadt, U, Escherich, G, Janka, G, Kabisch, H. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. Haematologica 2005;90:1701–5.Search in Google Scholar

33. “Neratinib tablets label” (PDF). U.S. Food and Drug Administration (FDA); 2017. http://medbox.iiab.me/kiwix/wikipedia_en_medicine_2019-12/A/Neratinib.Search in Google Scholar

34. Wang, B, Chu, D, Feng, Y, Shen, Y, Aoyagi-Scharber, M, Post, L. Discovery and characterization of (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, talazoparib), a novel, highly potent, and orally efficacious poly(ADP-ribose) polymerase-1/2 inhibitor, as an anticancer agent. Eur J Med Chem 2016;59:335–41. https://doi.org/10.1021/acs.jmedchem.5b01498.Search in Google Scholar PubMed

35. Yeates, C. Sitamaquine. Curr Opin Invest Drugs 2002;3:1446–50.Search in Google Scholar

36. Hong, DS, Rosen, P, Lockhart, AC, Fu, S, Janku, F, Kurzrock, R, et al.. A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors. Oncotarget 2015;6:18693–8. https://doi.org/10.18632/oncotarget.4472.Search in Google Scholar PubMed PubMed Central

37. Singh, RP, Patel, B, Kallender, H, Ottesen, LH, Adams, LM, Cox, DS. Population pharmacokinetics modeling and analysis of foretinib in adult patients with advanced solid tumors. J Clin Pharmacol 2015;55:1184–90. https://doi.org/10.1002/jcph.546.Search in Google Scholar PubMed

38. Dittrich, C, Coudert, B, Paz-Ares, L, Caponigro, F, Salzberg, M, Gamucci, T, et al.. Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer. Eur J Cancer 2003;39:330–6. https://doi.org/10.1016/s0959-8049(02)00559-2.Search in Google Scholar PubMed

39. Judith, S, Scavone, SV, Pinter, CD, Hamelehle, KL, Von Hoff, DD, Jackson, RC. Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro. Cancer Res 1987;47:4299–304.Search in Google Scholar

40. Sri Ramya, PV, Guntuku, L, Angapelly, S, Karri, S, Digwal, CS, Babu, BN, et al.. Curcumin inspired 2-chloro/phenoxy quinoline analogues: synthesis and biological evaluation as potential anticancer agents. Bioorg Med Chem Lett 2018;28:892–8. https://doi.org/10.1016/j.bmcl.2018.01.070.Search in Google Scholar PubMed

41. Wang, B, Li, Q, Shi, W, Chen, L, Sun, J. Design, synthesis, and cytotoxic evaluation of novel furo[2,3-b]quinoline derivatives. Chem Biol Drug Des 2018;91:957–61. https://doi.org/10.1111/cbdd.13154.Search in Google Scholar PubMed

42. Jafaria, F, Baghayi, H, Lavaee, P, Hadizadeh, F, Soltani, F, Moallemzadeh, H, et al.. Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents. Eur J Med Chem 2019;164:292–8. https://doi.org/10.1016/j.ejmech.2018.12.060.Search in Google Scholar PubMed

43. Malayeri, SO, Abnous, K, Arab, A, Akaberi, M, Mehri, S, Zarghi, A, et al.. Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents. Bioorg Med Chem 2017;25:1294–9. https://doi.org/10.1016/j.bmc.2016.12.050.Search in Google Scholar PubMed

44. Palluotto, F, Sosic, A, Pinato, O, Zoidis, G, Catto, M, Sissi, C, et al.. Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties. Eur J Med Chem 2016;123:704–8. https://doi.org/10.1016/j.ejmech.2016.07.063.Search in Google Scholar PubMed

45. Sidoryk, K, Switalsk, M, Jaromin, A, Cmoch, P, Bujak, I, Kaczmarska, M, et al.. The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents. Eur J Med Chem 2015;105:208–14. https://doi.org/10.1016/j.ejmech.2015.10.022.Search in Google Scholar PubMed

46. Lu, X, Ying, H, Ma, X, Qiu, N, Wu, P, Yang, B, et al.. Design, synthesis and biological evaluation of novel 4-alkynyl-quinoline derivatives as PI3K/mTOR dual inhibitors. Eur J Med Chem 2015;99:36–42. https://doi.org/10.1016/j.ejmech.2015.05.025.Search in Google Scholar PubMed

47. Shobeiri, N, Rashedi, M, Mosaffa, F, Zarghi, A, Ghandadi, M, Ghasemi, A, et al.. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors. Eur J Med Chem 2016;114:14–22. https://doi.org/10.1016/j.ejmech.2016.02.069.Search in Google Scholar PubMed

48. Bassyouni, FA, Abu-Baker, SM, Mahmoud, K, Moharam, M, El-Nakkady, SS, Rehim, MA. Synthesis and biological evaluation of some new triazolo[1,5-a]quinoline derivatives as anticancer and antimicrobial agents. RSC Adv 2014;4:24131–6. https://doi.org/10.1039/c3ra46961a.Search in Google Scholar

49. Chan, SH, Chui, CH, Chan, SW, Kok, SHL, Chan, D, Tsoi, MYT, et al.. Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents. ACS Med Chem Lett 2013;4:170–8. https://doi.org/10.1021/ml300238z.Search in Google Scholar PubMed PubMed Central

50. Li, S, Zhao, Y, Yali, KW, Han, GJ, Cui, B, Gong, P. Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors. Bioorg Med Chem 2013;21:2843–8. https://doi.org/10.1016/j.bmc.2013.04.013.Search in Google Scholar PubMed

51. Zhou, S, Liao, H, Liu, M, Feng, G, Fu, B, Li, R, et al.. Discovery and biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors. Bioorg Med Chem 2014;22:6438–44. https://doi.org/10.1016/j.bmc.2014.09.037.Search in Google Scholar PubMed

52. El-Agrody, AM, Abd-Rabboh, HSM, Al-Ghamdi, AM. Synthesis, antitumor activity, and structure–activity relationship of some 4H-pyrano[3,2-h]quinoline and 7H-pyrimido[4′,5′:6,5]pyrano[3,2-h]quinoline derivatives. Med Chem Res 2013;22:1339–44. https://doi.org/10.1007/s00044-012-0142-7.Search in Google Scholar

53. Razieh, G, Ebrahim, A, Maria, GF, Vincenzo, P, Afshin, Z. Lett Drug Des Discov 2016;13:89–94.Search in Google Scholar

54. Koprulu, TK, Okten, S, Tekin, S, Cakmak, O. Biological evaluation of some quinoline derivatives with different functional groups as anticancer agents. J Biochem Mol Toxicol 2019;33:e22260. https://doi.org/10.1002/jbt.22260.Search in Google Scholar PubMed

55. Liao, W, HuG, Guo, Z, Sun, G, Zhang, L, Bu, Y, et al.. Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors. Bioorg Med Chem 2015;23:4410–22. https://doi.org/10.1016/j.bmc.2015.06.026.Search in Google Scholar PubMed

56. Cañete, TA, Armijoa, F, Del vallea, MA, Tapiaa, RA, Theodulozb, C, Pessoaa, D, et al.. J Chil Chem Soc 2012;57:1126. https://doi.org/10.4067/s0717-97072012000200015.Search in Google Scholar

57. Li, K, Li, Y, Zhou, D, Fan, Y, Guo, H, Ma, T, et al.. Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors. Bioorg Med Chem 2016;24:1889–94. https://doi.org/10.1016/j.bmc.2016.03.016.Search in Google Scholar PubMed

58. Al-Bayati, RI, Ahamad, MR, Ahamed, LS. Synthetic access to noncanonical strigolactones: syntheses of carlactonic acid and methyl carlactonoate. Am J Org Chem 2015;5:125–9.Search in Google Scholar

59. Santoshkumar, S, Manjulatha, K, Satyanarayan, ND, Anantacharya, R, Harishkumar, S, Harishkumar, HN, et al.. ADME and potential in silico g6pdh inhibitory activity of novel 2-(1-benzofuran-2-yl)-4-(5-phenyl-4h-1, 2, 4-triazol-3-yl) quinoline derivatives. Int J Pharm Pharmaceut Sci 2016;8:313–8. https://doi.org/10.22159/ijpps.2016v8i11.14791.Search in Google Scholar

60. Wang, Y, Ai, J, Wang, Y, Chen, Y, Wang, L, Liu, G, et al.. Synthesis and c-Met Kinase Inhibition of 3,5-Disubstituted and 3,5,7-Trisubstituted Quinolines: Identification of 3-(4-Acetylpiperazin1-yl)-5-(3-nitrobenzylamino)-7-(trifluoromethyl)quinoline as a Novel Anticancer Agent. J Med Chem 2011;54:2127–32. https://doi.org/10.1021/jm101340q.Search in Google Scholar PubMed

61. Marganakop, SB, Kamble, RR, Taj, T, Kariduraganvar, MY. n efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatized with 1,3,4-thiadiazole as anticancer and anti-tubercular agents. Med Chem Res 2012;21:185–91. https://doi.org/10.1007/s00044-010-9522-z.Search in Google Scholar

62. Li, Y, Shi, X, Xie, N, Zhao, Y, Li, S. 3,3-Dimethyl-1H-pyrrolo[3,2-g]quinolin-2(3H)-one derivatives as novel Raf kinase inhibitors. Med Chem Commun 2013;4:367–72. https://doi.org/10.1039/c2md20275a.Search in Google Scholar

63. Scott, DA, Balliet, CL, Cook, DJ, Davies, AM, Gero, TW, Omer, CA, et al.. Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase. Bioorg Med Chem Lett 2009;19:697–700. https://doi.org/10.1016/j.bmcl.2008.12.046.Search in Google Scholar PubMed

64. Mai, A, Rotili, D, Tarantino, D, Nebbioso, A, Castellano, S, Sbardella, G, et al.. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases. Bioorg Med Chem Lett 2009;19:1132–5. https://doi.org/10.1016/j.bmcl.2008.12.097.Search in Google Scholar PubMed

65. Selim, MR, Zahran, MA, Belal, A, Abusaif, MS, Shedid, SA, Mehany, ABM, et al.. Hybridized anti-cancer agents. Med Chem 2019;19:439–46. https://doi.org/10.2174/1871520618666181112121058.Search in Google Scholar PubMed

66. Karthikeyan, C, Lee, C, Moore, J, Mittal, R, Suswam, EA, Abbott, KL, et al.. IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells. Bioorg Med Chem 2015;23:602–11. https://doi.org/10.1016/j.bmc.2014.11.043.Search in Google Scholar PubMed PubMed Central

Published Online: 2021-10-26

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Magnetic characterization of magnetoactive elastomers containing magnetic hard particles using first-order reversal curve analysis
  4. Microscopic understanding of particle-matrix interaction in magnetic hybrid materials by element-specific spectroscopy
  5. Biodeinking: an eco-friendly alternative for chemicals based recycled fiber processing
  6. Bio-based polyurethane aqueous dispersions
  7. Cellulose-based polymers
  8. Biodegradable shape-memory polymers and composites
  9. Natural substances in cancer—do they work?
  10. Personalized and targeted therapies
  11. Identification of potential histone deacetylase inhibitory biflavonoids from Garcinia kola (Guttiferae) using in silico protein-ligand interaction
  12. Chemical computational approaches for optimization of effective surfactants in enhanced oil recovery
  13. Social media and learning in an era of coronavirus among chemistry students in tertiary institutions in Rivers State
  14. Techniques for the detection and quantification of emerging contaminants
  15. Occurrence, fate, and toxicity of emerging contaminants in a diverse ecosystem
  16. Updates on the versatile quinoline heterocycles as anticancer agents
  17. Trends in microbial degradation and bioremediation of emerging contaminants
  18. Power to the city: Assessing the rooftop solar photovoltaic potential in multiple cities of Ecuador
  19. Phytoremediation as an effective tool to handle emerging contaminants
  20. Recent advances and prospects for industrial waste management and product recovery for environmental appliances: a review
  21. Integrating multi-objective superstructure optimization and multi-criteria assessment: a novel methodology for sustainable process design
  22. A conversation on the quartic equation of the secular determinant of methylenecyclopropene
  23. Recent developments in the synthesis and anti-cancer activity of acridine and xanthine-based molecules
  24. An overview of in silico methods used in the design of VEGFR-2 inhibitors as anticancer agents
  25. Fragment based drug design
  26. Advances in heterocycles as DNA intercalating cancer drugs
  27. Systems biology–the transformative approach to integrate sciences across disciplines
  28. Pharmaceutical interest of in-silico approaches
  29. Membrane technologies for sports supplementation
  30. Fused pyrrolo-pyridines and pyrrolo-(iso)quinoline as anticancer agents
  31. Membrane applications in the food industry
  32. Membrane techniques in the production of beverages
  33. Statistical methods for in silico tools used for risk assessment and toxicology
  34. Dicarbonyl compounds in the synthesis of heterocycles under green conditions
  35. Green synthesis of triazolo-nucleoside conjugates via azide–alkyne C–N bond formation
  36. Anaerobic digestion fundamentals, challenges, and technological advances
  37. Survival is the driver for adaptation: safety engineering changed the future, security engineering prevented disasters and transition engineering navigates the pathway to the climate-safe future
https://doi.org/10.1515/psr-2021-0040
Keywords for this article
anticancer agents; classical methods; heterocyclic compounds; marketed drugs; natural sources; quinolines

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Magnetic characterization of magnetoactive elastomers containing magnetic hard particles using first-order reversal curve analysis
  4. Microscopic understanding of particle-matrix interaction in magnetic hybrid materials by element-specific spectroscopy
  5. Biodeinking: an eco-friendly alternative for chemicals based recycled fiber processing
  6. Bio-based polyurethane aqueous dispersions
  7. Cellulose-based polymers
  8. Biodegradable shape-memory polymers and composites
  9. Natural substances in cancer—do they work?
  10. Personalized and targeted therapies
  11. Identification of potential histone deacetylase inhibitory biflavonoids from Garcinia kola (Guttiferae) using in silico protein-ligand interaction
  12. Chemical computational approaches for optimization of effective surfactants in enhanced oil recovery
  13. Social media and learning in an era of coronavirus among chemistry students in tertiary institutions in Rivers State
  14. Techniques for the detection and quantification of emerging contaminants
  15. Occurrence, fate, and toxicity of emerging contaminants in a diverse ecosystem
  16. Updates on the versatile quinoline heterocycles as anticancer agents
  17. Trends in microbial degradation and bioremediation of emerging contaminants
  18. Power to the city: Assessing the rooftop solar photovoltaic potential in multiple cities of Ecuador
  19. Phytoremediation as an effective tool to handle emerging contaminants
  20. Recent advances and prospects for industrial waste management and product recovery for environmental appliances: a review
  21. Integrating multi-objective superstructure optimization and multi-criteria assessment: a novel methodology for sustainable process design
  22. A conversation on the quartic equation of the secular determinant of methylenecyclopropene
  23. Recent developments in the synthesis and anti-cancer activity of acridine and xanthine-based molecules
  24. An overview of in silico methods used in the design of VEGFR-2 inhibitors as anticancer agents
  25. Fragment based drug design
  26. Advances in heterocycles as DNA intercalating cancer drugs
  27. Systems biology–the transformative approach to integrate sciences across disciplines
  28. Pharmaceutical interest of in-silico approaches
  29. Membrane technologies for sports supplementation
  30. Fused pyrrolo-pyridines and pyrrolo-(iso)quinoline as anticancer agents
  31. Membrane applications in the food industry
  32. Membrane techniques in the production of beverages
  33. Statistical methods for in silico tools used for risk assessment and toxicology
  34. Dicarbonyl compounds in the synthesis of heterocycles under green conditions
  35. Green synthesis of triazolo-nucleoside conjugates via azide–alkyne C–N bond formation
  36. Anaerobic digestion fundamentals, challenges, and technological advances
  37. Survival is the driver for adaptation: safety engineering changed the future, security engineering prevented disasters and transition engineering navigates the pathway to the climate-safe future
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/psr-2021-0040/html
Scroll to top button